Breaking News
Sort by:
Top Post
Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial
Abbott (NYSE: ABT) today announced new, late-breaking data from the global Leadless II IDE study evaluating […]
Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands
Caption Health and Ultromics, leaders in using AI to improve heart ultrasound diagnostics, today announced […]
NHS Offers Home Blood Pressure Checks to Save Thousands of Lives
Hundreds of thousands of people will be able to test their blood pressure at home, […]
BHF Teams Up With The Francis Crick Institute to Bolster Cardiovascular Research
BHF have teamed up with the Francis Crick Institute to improve understanding of cardiovascular health […]
BHF Research Could Help Detect Early Signs of Heart Failure in Diabetic Patients
New research that BHF have funded in Leicester could help understand how heart failure can […]
FDA Approves Repatha ® (evolocumab) in Pediatric Patients Age 10 And Older With Heterozygous Familial Hypercholesterolemia
Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Repatha ® (evolocumab) as an […]
Drug Could Help Hearts Recover After Heart Attack
A drug used to treat certain cancers could improve recovery after a heart attack by […]
Q’Apel Medical Launches Armadillo – A New Radial Artery Access Platform to Meet the Needs of Physicians and Patients
Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device […]
Nationwide Roll-Out of NHS High Street Heart Checks to Save Thousands of Lives
Thousands of lives will be saved thanks to more blood pressure checks in high street […]
Ultromics Raises $33M in Series B Funding to Help Transform Cardiac Disease Treatment
Ultromics, a leader in AI enabled cardiovascular imaging solutions, announced today that it has raised […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more